National Center for Complementary & Alternative Medicine; Notice of Meeting, 64656 [07-5665]

Download as PDF 64656 Federal Register / Vol. 72, No. 221 / Friday, November 16, 2007 / Notices Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 7073, Bethesda, MD 20892–8329, 301–496– 0694, msalin@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower, 93.399, Cancer Control, National Institutes of Health, HHS) Dated: November 7, 2007. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–5677 Filed 11–15–07; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Complementary & Alternative Medicine; Notice of Meeting mstockstill on PROD1PC66 with NOTICES Pursuant to Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the National Advisory Council for Complementary and Alternative Medicine (NACCAM) meeting. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. A portion of the meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applicants and/ or contract proposals and the discussion could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Council for Complementary and Alternative Medicine. Date: February 1, 2008. Closed: 8 a.m. to 12 p.m. Agenda: To review and evaluate grant applications and/or proposals. Open: 1 p.m. to 4:30 p.m. VerDate Aug<31>2005 21:48 Nov 15, 2007 Jkt 214001 Agenda: Opening remarks by the Acting Director of National Center for Complementary and Alternative Medicine, presentation of a new research initiative, and other business of the Council. Place: National Institutes of Health, Neuroscience Building, 6001 Executive Boulevard, Conference Rooms C & D, Bethesda, MD 20892. Contact Person: Martin H. Goldrosen, PhD, Executive Secretary, National Center for Complementary, and Alternative Medicine, National Institutes of Health, 6707 Democracy Blvd., Suite 401, Bethesda, MD 20892, (301) 594–2014. The public comments session is scheduled from 4–4:30 p.m., but could change depending on the actual time spent on each agenda item. Each speaker wil be permitted 5 minutes for their presentation. Interested individuals and representatives of organizations are requested to notify Dr. Martin H. Goldrosen, National Center for Complementary and Alternative Medicine, NIH, 6707 Democracy Boulevard, Suite 401, Bethesda, Maryland 20892, 301–594–2014, Fax: 301–480–9970. Letters of intent to present comments, along with a brief description of the organization represented, should be received no later than 5 p.m. on January 30, 2008. Only one representative of an organization may present oral comments. Any person attending the meeting who does not request an opportunity to speak in advance of the meeting may be considered for oral presentation, if time permits, and at the discretion of the Chairperson. In addition, written comments may be submitted to Dr. Martin H. Goldrosen at the address listed above up to ten calendar days (February 11, 2008) following the meeting. Copies of the meeting agenda and the roster of members will be furnished upon request by contacting Dr. Martin H. Goldrosen, Executive Secretary, NACCAM, National Center for Complementary and Alternative Medicine, National Institutes of Health, 6707 Democracy Boulevard, Suite 401, Bethesda, Maryland 20892, 301–594– 2014, Fax 301–480–9970, or via e-mail at naccames@mail.nih.gov. In the interest of security, NIH has instituted stringent procedures for entrance into the building by nongovernment employees. Persons without a government I.D. will need to show a photo I.D. and signin at the security desk upon entering the building. Dated: November 7, 2007. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–5665 Filed 11–15–07; 8:45 am] BILLING CODE 4140–01–M PO 00000 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Eye Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Eye Institute Special Emphasis Panel; Pathways to Independence K99/R00 Applications. Date: November 27, 2007. Time: 1 p.m. to 2:30 p.m. Agenda: To review and evaluate grant applications. Place: National Eye Institute, 5635 Fishers Lane, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Anne E. Schaffner, PhD, Scientific Review Administrator, Division of Extramural Research, National Eye Institute, 5635 Fishers Lane, Suite 1300, MSC 9300, Bethesda, MD 20892–9300, (301) 451–2020, aes@nei.nih.gov. Name of Committee: National Eye Institute Special Emphasis Panel; Pathways to Independence Applications II. Date: November 28, 2007. Time: 12 p.m. to 1:30 p.m. Agenda: To review and evaluate grant applications. Place: National Eye Institute, 5635 Fishers Lane, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Anne E. Schaffner, PhD, Scientific Review Administrator, Division of Extramural Research, National Eye Institute, 5635 Fishers Lane, Suite 1300, MSC 9300, Bethesda, MD 20892–9300, (301) 451–2020, aes@nei.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.867, Vision Research, National Institutes of Health, HHS) Dated: November 6, 2007. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–5664 Filed 11–15–07; 8:45 am] BILLING CODE 4140–01–M Frm 00083 Fmt 4703 Sfmt 4703 E:\FR\FM\16NON1.SGM 16NON1

Agencies

[Federal Register Volume 72, Number 221 (Friday, November 16, 2007)]
[Notices]
[Page 64656]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-5665]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Complementary & Alternative Medicine; Notice 
of Meeting

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the National 
Advisory Council for Complementary and Alternative Medicine (NACCAM) 
meeting.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    A portion of the meeting will be closed to the public in accordance 
with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), 
Title 5 U.S.C., as amended. The grant applicants and/or contract 
proposals and the discussion could disclose confidential trade secrets 
or commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Council for Complementary 
and Alternative Medicine.
    Date: February 1, 2008.
    Closed: 8 a.m. to 12 p.m.
    Agenda: To review and evaluate grant applications and/or 
proposals.
    Open: 1 p.m. to 4:30 p.m.
    Agenda: Opening remarks by the Acting Director of National 
Center for Complementary and Alternative Medicine, presentation of a 
new research initiative, and other business of the Council.
    Place: National Institutes of Health, Neuroscience Building, 
6001 Executive Boulevard, Conference Rooms C & D, Bethesda, MD 
20892.
    Contact Person: Martin H. Goldrosen, PhD, Executive Secretary, 
National Center for Complementary, and Alternative Medicine, 
National Institutes of Health, 6707 Democracy Blvd., Suite 401, 
Bethesda, MD 20892, (301) 594-2014.
    The public comments session is scheduled from 4-4:30 p.m., but 
could change depending on the actual time spent on each agenda item. 
Each speaker wil be permitted 5 minutes for their presentation. 
Interested individuals and representatives of organizations are 
requested to notify Dr. Martin H. Goldrosen, National Center for 
Complementary and Alternative Medicine, NIH, 6707 Democracy 
Boulevard, Suite 401, Bethesda, Maryland 20892, 301-594-2014, Fax: 
301-480-9970. Letters of intent to present comments, along with a 
brief description of the organization represented, should be 
received no later than 5 p.m. on January 30, 2008. Only one 
representative of an organization may present oral comments. Any 
person attending the meeting who does not request an opportunity to 
speak in advance of the meeting may be considered for oral 
presentation, if time permits, and at the discretion of the 
Chairperson. In addition, written comments may be submitted to Dr. 
Martin H. Goldrosen at the address listed above up to ten calendar 
days (February 11, 2008) following the meeting.
    Copies of the meeting agenda and the roster of members will be 
furnished upon request by contacting Dr. Martin H. Goldrosen, 
Executive Secretary, NACCAM, National Center for Complementary and 
Alternative Medicine, National Institutes of Health, 6707 Democracy 
Boulevard, Suite 401, Bethesda, Maryland 20892, 301-594-2014, Fax 
301-480-9970, or via e-mail at naccames@mail.nih.gov.
    In the interest of security, NIH has instituted stringent 
procedures for entrance into the building by nongovernment 
employees. Persons without a government I.D. will need to show a 
photo I.D. and sign-in at the security desk upon entering the 
building.

    Dated: November 7, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-5665 Filed 11-15-07; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.